Scientists find gene that inhibits pancreas cancer spread

April 29, 2012 in Cancer

Scienctists discover a gene dubbed USP9X in a study of pancreatic cancer in mice

Scientists have identified a gene that slows the spread of pancreatic cancer tumours, paving the way for targeted treatment of one of the deadliest forms of the disease, said a paper published Sunday. After discovering the gene dubbed USP9X at work in a study of pancreatic cancer in mice, the international research team found it also played a role in humans.

Scientists have identified a gene that slows the spread of pancreatic cancer tumours, paving the way for targeted treatment of one of the deadliest forms of the disease, said a paper published Sunday.

After discovering the gene dubbed USP9X at work in a study of pancreatic cancer in mice, the international research team found it also played a role in humans.

"We looked in human tumour specimens and we found that it was missing in a fraction of patients -- the patients that did very poorly ... the people who died the fastest," researcher David Tuveson told AFP.

"Patients that had a low level of the gene expressed ... they died very quickly after their operation and the patients who at the end of their life had lots of metastasis (spreading of the cancer), they had also a very low level of this protein."

The existence of the gene, which is found in all of our cells but goes missing in some tumours, was known before but not its role as a cancer suppressor, said Tuveson.

Three other pancreatic tumour are known to exist, but this is the one whose absence "probably causes -- that is what kills people with ," said the scientist.

The discovery means that "we can wake up the gene by using drugs" known as epigenetic modulators, he added.

"Our observation allows us to potentially treat people that have lost this gene in the pancreas tumours. It allows us to offer a therapy for the patients that actually have the worst prognosis."

Tuveson said these kinds of drugs have already been developed, "but people haven't figured out where exactly they would be useful.

"We are proposing that these drugs would be useful in this subset of ."

Pancreatic cancer kills about 96 percent of its victims within five years of diagnosis, one of the lowest cancer survival rates.

Early diagnosis is difficult, so the disease is often discovered only after it has already spread.

(c) 2012 AFP

5 /5 (7 votes)  

Rank 5 /5 (7 votes)
Relevant PhysicsForums posts

More news stories

Older prostate cancer patients should think twice before undergoing treatment

Older prostate cancer patients with other underlying health conditions should think twice before committing to surgery or radiation therapy for their cancer, according to a multicenter study led by researchers in the UCLA ...

Cancer created 11 hours ago | popularity not rated yet | comments 0 | with audio podcast

Two radiotherapy treatments show similar morbidity, cancer control after prostatectomy

Intensity-modulated radiation therapy has become the most commonly used type of radiation in prostate cancer, but research from the University of North Carolina suggests that the therapy may not be more effective than older, ...

Cancer created 13 hours ago | popularity not rated yet | comments 0

The compound in the Mediterranean diet that makes cancer cells 'mortal'

New research suggests that a compound abundant in the Mediterranean diet takes away cancer cells' "superpower" to escape death. By altering a very specific step in gene regulation, this compound essentially re-educates cancer ...

Cancer created 13 hours ago | popularity 4.8 / 5 (12) | comments 2 | with audio podcast

CT radiation risk less than risk of examination indicator

(HealthDay)—For young adults needing either a chest or abdominopelvic computed tomography (CT), the short-term risk of death from underlying morbidity is greater than the long-term risk of radiation-induced ...

Cancer created 14 hours ago | popularity not rated yet | comments 0

Team finds mechanism linking key inflammatory marker to cancer

In a new study described in the journal Oncogene, researchers reveal how a key player in cell growth, immunity and the inflammatory response can be transformed into a primary contributor to tumor growth.

Cancer created 20 hours ago | popularity not rated yet | comments 0 | with audio podcast


Nobel laureate plays down flu pandemic scaremongering

A Nobel prize-winning scientist Tuesday played down "shock-horror scenarios" that a new virus strain will emerge with the potential to kill millions of people.

After a decade, global AIDS program looks ahead

(AP)—The decade-old law that transformed the battle against HIV and AIDS in developing countries is at a crossroads. The dream of future generations freed from the epidemic is running up against an era ...

Genetic predictors of postpartum depression uncovered

Johns Hopkins researchers say they have discovered specific chemical alterations in two genes that, when present during pregnancy, reliably predict whether a woman will develop postpartum depression.

Child maltreatment increases risk of adult obesity

Children who have suffered maltreatment are 36% more likely to be obese in adulthood compared to non-maltreated children, according to a new study by King's College London. The authors estimate that the prevention or effective ...

New immune system discovered

(Medical Xpress)—A research team, led by Jeremy Barr, a biology post-doctoral fellow, unveils a new immune system that protects humans and animals from infection.

Early-life traffic-related air pollution exposure linked to hyperactivity

Early-life exposure to traffic-related air pollution was significantly associated with higher hyperactivity scores at age 7, according to new research from the University of Cincinnati (UC) and Cincinnati Children's Hospital ...